About this trial
We hypothesize that focal vibration therapy will reduce pain, increase the mobilization of the glenohumeral joint, and will improve functionality in patients with adhesive capsulitis.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients aged > 18 years
Unilateral adhesive capsulitis of the shoulder
The symptom duration > 3 months
Shoulder pain
Disqualifiers
Previous shoulder surgeries
Massive, minor, and major rotator cuff tears
Pain and muscle strength loss due to neurological causes
History or presence of malignancy
Trial design
Parallel
Treatments tested in this trial
Focal VibrationTherapy
DeviceMyovolt delivers oscillatory mechanical vibration of focussed frequency and low amplitude to stimulate physiological benefits in soft tissues. Myovolt is non-aggressive and gentle to the body so can be safely targeted. Digitally tuned to transmit a discrete vibration frequency range between 30 - 100Hz for effective neuromuscular stimulation.
Treatment groups
Trial outcomes
Primary outcomes
Change from Baseline Shoulder Pain at 4 weeks
Evaluation of shoulder pain was performed using the Visual Analog Scale. The score is determined by measuring the distance (mm) on the 10-cm line between the "no pain" on the far left and "the most intense pain imaginable" on the far right.The patient places a mark at a point on the line corresponding to the patient's rating of pain intensity. A higher score indicates greater pain intensity.
Change from 4 weeks Shoulder Pain at 6 weeks
Evaluation of shoulder pain was performed using the Visual Analog Scale. The score is determined by measuring the distance (mm) on the 10-cm line between the "no pain" on the far left and "the most intense pain imaginable" on the far right.The patient places a mark at a point on the line corresponding to the patient's rating of pain intensity. A higher score indicates greater pain intensity.
Secondary outcomes
Change from Baseline Range of Motion of Shoulder Joint at 4 weeks
The joint movements of the affected shoulder was measured using a digital electrogoniometer. A higher score indicates greater improvement.
Change from 4 weeks Range of Motion of Shoulder Joint at 6 weeks
The joint movements of the affected shoulder was measured using a digital electrogoniometer. A higher score indicates greater improvement.
Change from Baseline Shoulder Function at 4 weeks
Function was assessed using the self-administered Shoulder Pain and Disability Index.The Shoulder Pain and Disability Index contains 13 items that assess two domains; a 5-item subscale that measures pain and an 8-item subscale that measures disability. Each subscale is summed and transformed to a score out of 100. A mean is taken of the two subscales to give a total score out of 100, higher score indicating greater impairment or disability.
Change from 4 weeks Shoulder Function at 6 weeks
Function was assessed using the self-administered Shoulder Pain and Disability Index.The Shoulder Pain and Disability Index contains 13 items that assess two domains; a 5-item sub-scale that measures pain and an 8-item sub-scale that measures disability. Each sub-scale is summed and transformed to a score out of 100. A mean is taken of the two sub-scales to give a total score out of 100, higher score indicating greater impairment or disability.
Other outcomes
Change from baseline Shoulder Muscle Tone at 6 weeks
The muscle tone which is a biomechanical property of the shoulder muscles will be evaluated with a portable hand-held myotonometer. This myotonometer (MyotonPRO - Tallinn, Estonia) is non-invasive and provides a quantitative assessment of a muscle's biomechanical properties. The MyotonPRO applies a short-intensity mechanical impulse on the skin overlying the muscle. The tissue's response then generates a signal that is recorded, and an internal software program produces an acceleration graph.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.